Abbott Laboratories (ABT) Buildings (2009 - 2025)

Abbott Laboratories has disclosed Buildings across 17 years of filings, most recently posting $4.5 billion for Q4 2025.

• Buildings for Q4 2025 came in at $4.5 billion, up 7.99% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.5 billion (up 7.99% YoY), and the FY2025 annual result was $4.5 billion, up 7.99% from the prior year.
• Buildings came in at $4.5 billion for Q4 2025 at Abbott Laboratories, up from $4.2 billion in the prior quarter.
• In the past five years, Buildings ranged from a high of $4.5 billion in Q4 2025 to a low of $4.0 billion in Q4 2021.
• The 5-year median for Buildings is $4.2 billion (2023), against an average of $4.2 billion.
• Across the five-year window, Buildings slipped 0.17% in 2021 and rose 7.99% in 2025, its largest moves.
• Abbott Laboratories' Buildings stood at $4.0 billion in 2021, then increased by 1.15% to $4.1 billion in 2022, then increased by 2.66% to $4.2 billion in 2023, then climbed by 1.11% to $4.2 billion in 2024, then increased by 7.99% to $4.5 billion in 2025.
• The last three Buildings figures came in at $4.5 billion (Q4 2025), $4.2 billion (Q4 2024), and $4.2 billion (Q4 2023), per Business Quant data.